Smart Nuclide Pharmaceutical Technology

Company Deals

Tot Biopharmaceutical Partners with Suzhou Smart Nuclide on Radioactive Drug Development

Fineline Cube Apr 25, 2023

China-based Tot Biopharmaceutical International Co., Ltd (HKG: 1875) has announced a strategic partnership with Suzhou...

Company Deals

Sanofi Completes Vicebio $1.6B Acquisition, Adds RSV Vaccine Platform

Company Drug

Juventas CAR-T LBCL Launch Marks Second Indication

Company Drug

BMS Breyanzi MZL FDA Approval First CAR-T

Company Deals

Formosa Pharma APP13007 Clobetasol ASEAN Deal with Rxilient